Slingshot Insights

Catalyst

Slingshot members are tracking this event:

PDUFA Date of June 30th for Radius' (RDUS) NDA for Abaloparatide-SC in Treatment of Postmenopausal Women with Osteoporosis

Source Link:: http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=982846

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

RDUS

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Mar 10 2017:Initially expected on March 30 2017, the PDUFA goal date extended by standard extension period of three months to June 30, 2017

http://ir.radiusphar...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Apr 28, 2017

Occurred Source:

http://ir.radiuspharm.com/releasedetail.cfm?ReleaseID=1023557

Related Projects

Discussing the market potential of TYMLOS (Abaloparatide) after approval and positive ACTIVExtend results in osteoporosis. RDUS, MRK, AMGN, LLY Executed On: Jun 23, 2017 at 11:30 AM EDT

Related Keywords Nda, Abaloparatide-sc, Postmenopausal Women, Osteoporosis, Pdufa, Tymlos, Tymlos